New genetic findings help explain inherited predisposition to myeloma

July 1, 2016, Institute of Cancer Research

Researchers have identified eight new genetic variations in the human genome that could be linked to an increased risk of developing myeloma. The findings provide additional evidence and build on existing research that suggests myeloma can run in families.

In the largest study of its kind, scientists at The Institute of Cancer Research, London, compared the genomes of patients with those of healthy individuals. The team also combined and re-analysed data from similar research undertaken as part of a genome-wide association study (GWAS). In total, the researchers compared DNA from 9,866 myeloma patients with 239,188 healthy adults.

Every year around 5,500 people in the UK are diagnosed with myeloma, a rare and incurable form of cancer affecting the in bone marrow, and around one in 115 men and one in 155 women in the general population will develop myeloma in their life time.

Eight (SNPs), inherited single letter variations in DNA, were linked to increased susceptibility of developing myeloma.

These SNPs were located in regions of the genome involved in regulating genes linked to cell processes known to go wrong in myeloma development. These included the production of antibodies in plasma cells, as well as the regulation of gene activity and the maturation of these cells.

The ICR research suggests that subtle effects on the activity of key genes could mean that the proper development of plasma cells breaks down, increasing the likelihood of developing myeloma. However, further work would need to be undertaken to fully understand this.

In total 17 risk variants for myeloma have now been identified by the ICR team. It is estimated that the risk variants identified so far account for just 20% of the heritable risk factors connected to myeloma and further GWAS studies of patients are planned.

The research, published online in the journal Nature Communications today (Friday), was principally funded by the charities Bloodwise and Myeloma UK, with additional support from Cancer Research UK and Rosetrees Trust.

Study leader Richard Houlston, Professor of Molecular and Population Genetics at The Institute of Cancer Research, London, said: "Our study expands our understanding of how inherited risk factors can influence the risk of myeloma. We know that the inherited risk of myeloma does not come from just one or two major risk genes, as can be the case with breast cancer, but from multiple different genetic variants, each with only a small individual effect on risk. Identifying more of these variants gives us new insights into the potential causes of the disease, and open up new strategies for prevention."

Myeloma UK Chief Executive Eric Low said, "This research allows us to build a greater understanding of the genetics of myeloma and it could play a vital role in the future development of preventative and curative strategies. It is important to note, however, that myeloma accounts for only 2% of all cancers, so whilst this research takes an extremely important look at the familial risk of developing myeloma, the overall risk to the general populace of developing myeloma is small."

Dr Alasdair Rankin, Research Director at Bloodwise, said: "These findings give an insight into the genetic and biological basis of why myeloma can occasionally run in families. It is important to remember that while relatives of patients may have a higher risk of developing myeloma than the rest of the population, their absolute risk is still low. Further studies could help guide the development of new drugs to treat this cancer in the future. With a more complete genetic picture, it may even be possible to identify those family members at an increased risk and find ways to prevent them from developing myeloma."

Explore further: Researchers discover underlying cause of myeloma

More information: The report is published online in the journal Nature Communications on Friday 1st July 2016 under the title, 'Genome-wide association study identifies multiple susceptibility loci for multiple myeloma'.

Related Stories

Researchers discover underlying cause of myeloma

February 11, 2016
Yale Cancer Center researchers have identified what causes a third of all myelomas, a type of cancer affecting plasma cells. The findings, published Feb. 10 in the New England Journal of Medicine, could fundamentally change ...

Sylvester researchers develop novel disease model to study multiple myeloma

May 5, 2016
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have developed an animal model that allows them to better understand the mechanisms that lead to the development of ...

Scientists find evidence of how incurable cancer develops

October 16, 2015
Researchers in the West Midlands have made a breakthrough in explaining how an incurable type of blood cancer develops from an often symptomless prior blood disorder. The findings could lead to more effective treatments and ...

Research team first to identify AF1q protein associated with multiple myeloma, EMD

June 10, 2016
A group of researchers from the University of Louisville, Japan and Austria is the first to identify a protein, AF1q, associated with multiple myeloma and a condition that occurs in approximately one-fourth of very aggressive ...

Major study links aging gene to blood cancer

August 18, 2013
A gene that helps control the ageing process by acting as a cell's internal clock has been linked to cancer by a major new study.

Rates of kidney failure due to blood cancer are declining

October 29, 2015
The risk of kidney failure caused by multiple myeloma appears to be declining, and survival is lengthening for patients who do develop kidney failure due to this cancer. The findings, which are published in a study appearing ...

Recommended for you

Fully reprogrammed virus offers new hope as cancer treatment

May 25, 2018
A cancer treatment that can completely destroy cancer cells without affecting healthy cells could soon be a possibility, thanks to research led by Cardiff University.

Research could help fine-tune cancer treatment

May 25, 2018
Cancer therapies that cut off blood supply to a tumour could be more effective in combination with existing chemotherapeutic drugs—according to new research from the University of East Anglia.

Increasing physical activity linked to better immunity in breast cancer patients, study finds

May 25, 2018
A new study from the University of Toronto's Faculty of Kinesiology & Physical Education has found that moderate to vigorous physical activity may help regulate the levels of C-reactive protein – an important biomarker ...

Low-fat diet tied to better breast cancer survival

May 24, 2018
(HealthDay)—Breast cancer patients who adopted a low-fat diet were more likely to survive for at least a decade after diagnosis, compared to patients who ate fattier fare, new research shows.

A cascade of immune processes offers insights to triple-negative breast cancer

May 24, 2018
Cancer is crafty. To survive and thrive, tumors find a way of thwarting our body's natural systems.

By forming clots in tumors, immune cell aids lung cancer's spread

May 24, 2018
University of North Carolina Lineberger Comprehensive Cancer Center researchers have found that by helping to form clots within tumors, immune cells that flock to a particular type of lung cancer are actually building a foundation ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.